Cargando…
Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma
Calretinin (CALB2) is a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM). We previously reported that calretinin expression is regulated at the mRNA level. The presence of a medium-sized (573 nucleotide) 3′ untranslated region (3′UTR) predicted to contain binding sites for mi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447031/ https://www.ncbi.nlm.nih.gov/pubmed/28611824 http://dx.doi.org/10.3389/fgene.2017.00070 |
_version_ | 1783239223018520576 |
---|---|
author | Kresoja-Rakic, Jelena Sulemani, Merve Kirschner, Michaela B. Ronner, Manuel Reid, Glen Kao, Steven Schwaller, Beat Weder, Walter Stahel, Rolf A. Felley-Bosco, Emanuela |
author_facet | Kresoja-Rakic, Jelena Sulemani, Merve Kirschner, Michaela B. Ronner, Manuel Reid, Glen Kao, Steven Schwaller, Beat Weder, Walter Stahel, Rolf A. Felley-Bosco, Emanuela |
author_sort | Kresoja-Rakic, Jelena |
collection | PubMed |
description | Calretinin (CALB2) is a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM). We previously reported that calretinin expression is regulated at the mRNA level. The presence of a medium-sized (573 nucleotide) 3′ untranslated region (3′UTR) predicted to contain binding sites for miR-30a/b/c/d/e and miR-9 as well as an adenine/uridine-rich element (ARE) in all three transcripts arising from the CALB2 gene, suggests that calretinin expression is regulated via posttranscriptional mechanisms. Our aim was to investigate the role of the CALB2-3′UTR in the posttranscriptional regulation of calretinin expression in MPM. CALB2-3′UTR was inserted downstream of the luciferase reporter gene using pmiRGLO vector and reporter expression was determined after transfection into MPM cells. Targeted mutagenesis was used to generate variants harboring mutated miR-30 family and ARE binding sites. Electrophoretic mobility shift assay was used to test for the presence of ARE binding proteins. CALB2-3′UTR significantly decreased luciferase activity in MPM cells. Analysis of mutation in the ARE site revealed a further destabilization of the reporter and human antigen R (HuR) binding to the ARE sequence was detected. The mutation of two miR-30 binding sites abolished CALB2-3′UTR destabilization effect; a transient delivery of miR-30e-5p mimics or anti-miR into MPM cells resulted in a significant decrease/increase of the luciferase reporter expression and calretinin protein, respectively. Moreover, overexpression of CALB2-3′UTR quenched the effect of miR-30e-5p mimics on calretinin protein levels, possibly by sequestering the mimics, thereby suggesting a competitive endogenous RNA network. Finally, by data mining we observed that expression of miR-30e-5p was negatively correlated with the calretinin expression in a cohort of MPM patient samples. Our data show the role of (1) adenine-uridine (AU)-binding proteins in calretinin stabilization and (2) miR-30e-5p in the posttranscriptional negative regulation of calretinin expression via interaction with its 3′UTR. Furthermore, our study demonstrates a possible physiological role of calretinin’s alternatively spliced transcripts. |
format | Online Article Text |
id | pubmed-5447031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54470312017-06-13 Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma Kresoja-Rakic, Jelena Sulemani, Merve Kirschner, Michaela B. Ronner, Manuel Reid, Glen Kao, Steven Schwaller, Beat Weder, Walter Stahel, Rolf A. Felley-Bosco, Emanuela Front Genet Genetics Calretinin (CALB2) is a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM). We previously reported that calretinin expression is regulated at the mRNA level. The presence of a medium-sized (573 nucleotide) 3′ untranslated region (3′UTR) predicted to contain binding sites for miR-30a/b/c/d/e and miR-9 as well as an adenine/uridine-rich element (ARE) in all three transcripts arising from the CALB2 gene, suggests that calretinin expression is regulated via posttranscriptional mechanisms. Our aim was to investigate the role of the CALB2-3′UTR in the posttranscriptional regulation of calretinin expression in MPM. CALB2-3′UTR was inserted downstream of the luciferase reporter gene using pmiRGLO vector and reporter expression was determined after transfection into MPM cells. Targeted mutagenesis was used to generate variants harboring mutated miR-30 family and ARE binding sites. Electrophoretic mobility shift assay was used to test for the presence of ARE binding proteins. CALB2-3′UTR significantly decreased luciferase activity in MPM cells. Analysis of mutation in the ARE site revealed a further destabilization of the reporter and human antigen R (HuR) binding to the ARE sequence was detected. The mutation of two miR-30 binding sites abolished CALB2-3′UTR destabilization effect; a transient delivery of miR-30e-5p mimics or anti-miR into MPM cells resulted in a significant decrease/increase of the luciferase reporter expression and calretinin protein, respectively. Moreover, overexpression of CALB2-3′UTR quenched the effect of miR-30e-5p mimics on calretinin protein levels, possibly by sequestering the mimics, thereby suggesting a competitive endogenous RNA network. Finally, by data mining we observed that expression of miR-30e-5p was negatively correlated with the calretinin expression in a cohort of MPM patient samples. Our data show the role of (1) adenine-uridine (AU)-binding proteins in calretinin stabilization and (2) miR-30e-5p in the posttranscriptional negative regulation of calretinin expression via interaction with its 3′UTR. Furthermore, our study demonstrates a possible physiological role of calretinin’s alternatively spliced transcripts. Frontiers Media S.A. 2017-05-29 /pmc/articles/PMC5447031/ /pubmed/28611824 http://dx.doi.org/10.3389/fgene.2017.00070 Text en Copyright © 2017 Kresoja-Rakic, Sulemani, Kirschner, Ronner, Reid, Kao, Schwaller, Weder, Stahel and Felley-Bosco. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Kresoja-Rakic, Jelena Sulemani, Merve Kirschner, Michaela B. Ronner, Manuel Reid, Glen Kao, Steven Schwaller, Beat Weder, Walter Stahel, Rolf A. Felley-Bosco, Emanuela Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma |
title | Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma |
title_full | Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma |
title_fullStr | Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma |
title_full_unstemmed | Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma |
title_short | Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma |
title_sort | posttranscriptional regulation controls calretinin expression in malignant pleural mesothelioma |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447031/ https://www.ncbi.nlm.nih.gov/pubmed/28611824 http://dx.doi.org/10.3389/fgene.2017.00070 |
work_keys_str_mv | AT kresojarakicjelena posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT sulemanimerve posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT kirschnermichaelab posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT ronnermanuel posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT reidglen posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT kaosteven posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT schwallerbeat posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT wederwalter posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT stahelrolfa posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma AT felleyboscoemanuela posttranscriptionalregulationcontrolscalretininexpressioninmalignantpleuralmesothelioma |